94259 ⎘
Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Sub-classes:PRODUCTION METHOD FOR T CELLS OR NK CELLS, MEDIUM FOR CULTURING T CELLS OR NK CELLS, METHOD FOR CULTURING T CELLS OR NK CELLS, METHOD FOR MAINTAINING UNDIFFERENTIATED STATE OF UNDIFFERENTIATED T CELLS, AND GROWTH-ACCELERATING AGENT FOR T CELLS OR NK CELLS
#2Production method for T cells or NK cells, medium for culturing T cells or NK cells, method for culturing T cells or NK cells, method for maintaining undifferentiated state of undifferentiated T cells, and growth-accelerating agent for T cells or NK cells
#3Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
#4Prodrugs of Nh-acidic compounds
#5PRODRUGS OF NH-ACIDIC COMPOUNDS
#6Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof
#7Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
#8Prodrugs of NH-acidic compounds
#9Processes for Preparing Quinoline Derivatives
#10Selective androgen receptor degrader (SARD) ligands and methods of use thereof
#11Selective androgen receptor degrader (SARD) ligands and methods of use thereof
#12Prodrugs of NH-acidic compounds
#13Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
#14Process for preparing quinoline derivatives
#15Aryl-quinoline derivatives
#16Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases
#17Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method
#188-hydroxy quinoline derivatives
#19Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
#20Intermediate compounds and processes for the preparation of quinoline derivatives such as laquinimod sodium
#218-hydroxy quinoline derivatives
#22Process for preparing quinoline derivatives
#23Intermediate compounds and processes for the preparation of quinoline derivatives such as Laquinimod sodium
#24Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
#25Nucleic acid detections and methods of their use
#26Aryl-quinoline derivatives
#27RESIST COMPOSITION FOR SEMICONDUCTOR, AND RESIST FILM AND PATTERN FORMING METHOD USING THE SAME
#28Quinoline derivatives and their use as 5-HTligands
#29LABELING COMPOSITION FOR INTRAOCULAR TISSUE, LABELING METHOD OF INTRAOCULAR TISSUE, AND SCREENING METHOD
#30Prodrugs of NH-acidic compounds
#31Quinoline derivatives and their use as 5-HT6 ligands
#32Microbiocides
#33Quinoline derivatives and their use as 5-HTligands
#34Argatroban formulations and methods for making and using same
#35Quinoline derivatives and their use as 5-HT6 ligands
#368-hydroxy quinoline derivatives
#378-hydroxy quinoline derivatives
#38Quinoline derivatives and their use as 5-ht6 ligands